Inman, Brant A <br/><br/>
Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial.  [electronic resource] 

 -  The Journal of urology  May 2006 
 - 1960; author reply 1960-1 p.  digital 
<br/><br/> Publication Type: Comment; Comparative Study; Letter 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/S0022-5347(05)00970-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>BCG Vaccine--administration & dosage<br/>Disease Progression<br/>Humans<br/>Neoplasm Recurrence, Local--prevention & control<br/>Neoplasm Staging<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Urinary Bladder Neoplasms--drug therapy